首页> 外国专利> STRATRIENS 9-ALPHA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STRATEGES

STRATRIENS 9-ALPHA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STRATEGES

机译:STRATRIENS 9-ALPHA取代为选择性效能策略

摘要

New strategy 9 alpha - replaced by a level 1 common formula,Space of frumula, R3, R7, R7,R13, R16, R17 and R17 'have various meanings as described in the description, while R9 is a linear or separator algebraic electrode, which can be partially or completely halogenated, containing 2 to 6 carbon atoms, an Ethiopian radical or a prop-1-nilo as active pharmaceutical ingredient, The preparation of estrogen receptor of mouse before IVF is closer to that of mouse uterus, and has a priority influence on the preparation of ovary compared with that of uterus,Its therapeutic use and drug forms containing new compounds. The invention also describes the use of these compounds in the treatment of diseases and conditions caused by pathogen defects.
机译:新策略9 alpha-被1级通用公式所替代,式子的空间,R3,R7,R7,R13,R16,R17和R17具有描述中所述的各种含义,而R9是线性或分隔符代数电极,可以部分或完全卤化,含有2至6个碳原子,埃塞俄比亚基团或prop-1-nilo作为活性药物成分。IVF之前小鼠的雌激素受体的制备更接近小鼠子宫,并且具有与子宫相比,其对卵巢的制备具有重要的影响,其治疗用途和含有新化合物的药物形式。本发明还描述了这些化合物在治疗由病原体缺陷引起的疾病和状况中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号